When is pneumococcal vaccine recommended?
CDC recommends pneumococcal vaccination for all adults 65 years or older.
Who should get Pneumovax 23?
PNEUMOVAX 23 is recommended by the CDC for people 65 years or older — even if they may have already received a dose of another vaccine for pneumococcal disease. It is also recommended for adults 19 to 64 years of age who have certain chronic conditions (diabetes, heart disease, or COPD).
Is pneumococcal vaccine same as flu shot?
If you get a flu shot, you may think you don’t need a pneumonia shot. However, this is not true. Pneumococcal vaccines (known by most people as pneumonia shots) protect against strains of a bacteria, streptococcus pneumonaie.
What’s the difference between PCV13 and PPSV23?
PPSV23 contains antigens from 23 common serotypes, while PCV13 contains antigens from 13 serotypes. Although both vaccines aim to induce immunity against the most common serotypes to cause clinical disease, there is substantial overlap in the antigens contained within each vaccine.
How often should a 70 year old get a pneumonia shot?
If you or a loved one is age 65 or older, getting vaccinated against pneumonia is a good idea — so good that the Centers for Disease Control (CDC) now recommends that everyone in this age group get vaccinated against pneumonia twice.
Which is better Prevnar 13 or Pneumovax 23?
The main difference between Pneumovax 23 and Prevnar 13 is how many different types of bacteria they target. Pneumovax 23 protects against 23 types of pneumococcal bacteria and is used in adults, while Prevnar 13 protects against 13 types of pneumococcal bacteria, and was designed primarily for children.
Which is better pneumonia vaccine or flu vaccine?
A flu shot protects against the flu and its complications, which may include forms of pneumonia. But it does not offer protection against the most common type of pneumonia, pneumcoccal disease. If you get a flu shot, you may think you don’t need a pneumonia shot. However, this is not true.
Do adults need pneumococcal vaccine?
All adults 65 years or older should receive 1 dose of pneumococcal polysaccharide vaccine (PPSV23). In addition, CDC recommends PCV13 based on shared clinical decision-making for adults 65 years or older who do not have an immunocompromising condition†, cerebrospinal fluid leak, or cochlear implant.